surpass cvot tirzepatide results C. Michael Gibson MD on X: "SURPASS-CVOT trial: was non-inferior to dulaglutide and superior to putative placebo for reducing the composite of CV death/HF events in patients with T2D and ASCVD. # Henry Han on X: "Ongoing

New, more effective molecules with optimized pharmacokinetics produce greater weight loss and some may be more effective for various metabolic disorders, through incorporation of one or more additional peptide epitopes

Because weight loss improves insulin sensitivity, many PCOS symptoms improve as well: more regular periods, reduced androgen levels (less acne, hirsutism), improved fertility, and better metabolic markers

Storage Instructions Lyophilized: 20 C in dry, dark place

For muscle loss, Nexira recommend Prothy, a hydrolized rice protein which is rich in all essential and semi-essential amino acids, while ginseng, guarana and the Cognivia-branded vegetal nootropic are recommended to improve energy and focus due to their ability to replenish energy stores and boost cognition

Regular monitoring of vital signs, weight loss progress, and side effects helps ensure both safety and effectiveness

Protocol for switching from low-dose tirzepatide (2.5 to 5 mg) If you were on tirzepatide 2.5 mg or 5 mg, your switch is the most straightforward